Literature DB >> 11050146

Neurotrophic factor expression after CNS viral injury produces enhanced sensitivity to psychostimulants: potential mechanism for addiction vulnerability.

M V Solbrig1, G F Koob, L H Parsons, T Kadota, N Horscroft, T Briese, W I Lipkin.   

Abstract

Hypothesized risk factors for psychostimulant, amphetamine, and cocaine abuse include dopamine (DA) receptor polymorphisms, HIV infection, schizophrenia, drug-induced paranoias, and movement disorders; however, the molecular, cellular, and biochemical mechanisms that predispose to drug sensitivity or drive the development of addiction are incompletely understood. Using the Borna disease rat, an animal model of viral-induced encephalopathy wherein sensitivity to the locomotor and stereotypic behavioral effects of d-amphetamine and cocaine is enhanced (Solbrig et al., 1994, 1998), we identify a specific neurotrophin expression pattern triggered by striatal viral injury that increases tyrosine hydroxylase activity, an early step in DA synthesis, to produce a phenotype of enhanced amphetamine sensitivity. The reactive neurotrophin pattern provides a molecular framework for understanding how CNS viral injury, as well as other CNS adaptations producing similar growth factor activation profiles, may influence psychostimulant sensitivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050146      PMCID: PMC6772732     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  Animal models of CNS viral disease: examples from borna disease virus models.

Authors:  Marylou V Solbrig
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-24

Review 2.  Borna disease virus.

Authors:  Mady Hornig; Thomas Briese; W Ian Lipkin
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

3.  A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.

Authors:  Marylou V Solbrig; Yijun Fan; Neal Hermanowicz; Maria Grazia Morgese; Andrea Giuffrida
Journal:  Exp Neurol       Date:  2010-09-09       Impact factor: 5.330

4.  Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.

Authors:  Marylou V Solbrig; Neal Hermanowicz
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

5.  Animal models of virus-induced neurobehavioral sequelae: recent advances, methodological issues, and future prospects.

Authors:  Marco Bortolato; Sean C Godar
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-05-18

Review 6.  The evolution of drug development in schizophrenia: past issues and future opportunities.

Authors:  William T Carpenter; James I Koenig
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

Review 7.  Characterizing intercellular signaling peptides in drug addiction.

Authors:  Elena V Romanova; Nathan G Hatcher; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  Neuropharmacology       Date:  2008-08-03       Impact factor: 5.250

8.  A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.

Authors:  Jean-Pierre Louboutin; Lokesh Agrawal; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.